BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36938523)

  • 1. Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning.
    Scotton WJ; Shand C; Todd E; Bocchetta M; Cash DM; VandeVrede L; Heuer H; ; Young AL; Oxtoby N; Alexander DC; Rowe JB; Morris HR; Boxer AL; Rohrer JD; Wijeratne PA
    Brain Commun; 2023; 5(2):fcad048. PubMed ID: 36938523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A data-driven model of brain volume changes in progressive supranuclear palsy.
    Scotton WJ; Bocchetta M; Todd E; Cash DM; Oxtoby N; VandeVrede L; Heuer H; ; Alexander DC; Rowe JB; Morris HR; Boxer A; Rohrer JD; Wijeratne PA
    Brain Commun; 2022; 4(3):fcac098. PubMed ID: 35602649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies.
    Scotton WJ; Shand C; Todd EG; Bocchetta M; Cash DM; VandeVrede L; Heuer HW; Young AL; Oxtoby N; Alexander DC; Rowe JB; Morris HR; ; Boxer AL; ; Rohrer JD; Wijeratne PA
    medRxiv; 2024 Mar; ():. PubMed ID: 38562801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
    Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
    Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
    Saito Y; Kamagata K; Wijeratne PA; Andica C; Uchida W; Takabayashi K; Fujita S; Akashi T; Wada A; Shimoji K; Hori M; Masutani Y; Alexander DC; Aoki S
    Front Neurol; 2022; 13():814768. PubMed ID: 35280291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.
    Brown JA; Hua AY; Trujllo A; Attygalle S; Binney RJ; Spina S; Lee SE; Kramer JH; Miller BL; Rosen HJ; Boxer AL; Seeley WW
    Neuroimage Clin; 2017; 16():564-574. PubMed ID: 28951832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [
    Hong J; Lu J; Liu F; Wang M; Li X; Clement C; Lopes L; Brendel M; Rominger A; Yen TC; Guan Y; Tian M; Wang J; Zuo C; Shi K;
    EBioMedicine; 2023 Nov; 97():104835. PubMed ID: 37839135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan.
    Planche V; Mansencal B; Manjon JV; Meissner WG; Tourdias T; Coupé P
    Brain Commun; 2024; 6(2):fcae055. PubMed ID: 38444913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
    Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
    Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Kantarci K; Eggers SD; Jack CR; Josephs KA
    Eur J Neurol; 2013 Apr; 20(4):629-37. PubMed ID: 23078273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.